Official UK procurement notice
PHE - Breast Cancer Test and Training System
Authority: Public Health England
What is being bought
Published requirement descriptionBreast cancer screening system
CPV: System, storage and content management software package
The lotProcurement structure
single lot · no lot value publishedLot #1The contracts supports the Breast Cancer Screening ProgrammeAwarded
The contracts supports the Breast Cancer Screening Programme. The aim of the Programme is to maximise screening sensitivity (diagnosing the disease in the population who have the disease) whilst also maximising screening specificity (correctly identifying those who do not have the disease).
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 8 Apr 2022, 11:45 BST
- Last source update
- 8 Apr 2022, 11:45 BST
- Authority reference
project_1325; ecm_7236- FTS notice number
2022/S 000-009466- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-032b95Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
PHE originally went out to market using the open procedure with only one tenderer (the existing supplier) expressing an interest. Subsequently that tenderer notified PHE that they could no longer fulfil the requirements of the specification due to a key member of staff moving to the University of Nottingham. The tenderer subsequently transferred the intellectual property to the University of Nottingham to help facilitate the continuance of programme monitoring.
The University of Nottingham have agreed to meet the specification requirements at the same cost as the bidder that originally tendered therefore ensuring value for money.
As there is only one supplier capable of meeting the requirements PHE used the negotiated procedure without prior publication to award the contract to the University of Nottingham under Regulations 32 (2) (b) (ii) and (iii).
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| UNIVERSITY OF NOTTINGHAM, THE | £505,614 † | — | Awarded |
Contracts
PHE - Breast Cancer Test and Training System · UNIVERSITY OF NOTTINGHAM, THE
- Signed
- 2 Mar 2020
- Value
- £505,614
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- UK Health Security AgencyReview body
Bidders & participating suppliers
1 commercial party on the notice- The University of NottinghamAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.